Sh Pharmaceutical reported CNY5.01B in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Sh Fosun Pharma CNY 1.57B 128.23M Dec/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 5.64B 3.31B Mar/2026